News

The company said that Stiolto Respimat (tiotropium bromide and olodaterol) is not indicated to treat asthma or acute deterioration of COPD, which is a serious but treatable lung

BPD is a field that includes cell engineering, continuous processing, formulation and analytical science, to support development of potential new therapies. The research collaboration will see MedImmune and

EastGate is aimed at using drug delivery innovations in the development of improved new formulations and alternative dosage forms of existing biologically active molecules. E-drops has been successfully

With the acquisition, AbbVie will now have access to Pharmacyclics’ Imbruvic11a (ibrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor used to treat hematological cancers. Imbruvica is approved for use

Currently, the company is exploring two combination treatments for relapsed ovarian cancer. As part of this advancement, a Phase II trial of CRLX101 plus Avastin is enrolling patients,

As part of the deal, NeuroVive Asia will get an upfront payment, a conditional milestone payment and royalty on potential future sales in South Korea. The deal will

The acquired business will now be combined with Ergomed’s existing fast growing post-marketing business, PrimeVigilance. The acquisition of Sound Opinion is part of Ergomed’s strategy of strengthening its

Designed using Visterra’s proprietary technology, VIS513 is a humanized monoclonal antibody that is designed to bind and potently neutralize all four serotypes of dengue virus. Preclinical trials of

Unituxin, a monoclonal antibody, is intended for use in children who have responded to an induction treatment with chemotherapy, followed by myeloablative therapy and autologous stem-cell transplantation. Neuroblastoma